search
Back to results

Confocal Endomicroscopy for Biliary Strictures -Phase I

Primary Purpose

Biliary Stricture

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ERCP and Confocal imaging
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Biliary Stricture focused on measuring Biliary Strictures, Cholangiocarcinoma, ERCP

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pre-ERCP: Age above 18; imaging consistent with stenosis/mass of the hilum/extra-hepatic bile duct with abnormal liver chemistry, or painless jaundice referred for ERCP.
  • Evidence of biliary obstruction as defined by elevated direct bilirubin (> 1.5ULN) and dilation of the common or hepatic ducts > 8mm) on imaging studies.

Exclusion Criteria:

  • Unwilling/unable to consent.
  • Definite pancreatic mass on CT/MR.
  • Allergy to Fluorescein.
  • Pregnancy (patient who could be pregnant will undergo pregnancy testing as per routine care)
  • Indwelling metal biliary stent.

Sites / Locations

  • Mayo Clinic

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

1. To compare confocal image characteristics of benign vs. malignant biliary strictures

Outcomes

Primary Outcome Measures

Primary Aim: 1. To compare confocal image characteristics of benign vs. malignant biliary strictures.

Secondary Outcome Measures

Secondary Aim: 1. To compare the technical feasibility (percentage of images rated as adequate or better) and the quality of the images obtained via fluoroscopy-guided pCLE versus cholangioscopy-guided pCLE.

Full Information

First Posted
May 1, 2009
Last Updated
February 22, 2012
Sponsor
Mayo Clinic
Collaborators
Leadiant Biosciences, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00892632
Brief Title
Confocal Endomicroscopy for Biliary Strictures -Phase I
Official Title
A Pilot Study of Confocal Endomicroscopy for Biliary Strictures - Phase I
Study Type
Interventional

2. Study Status

Record Verification Date
February 2012
Overall Recruitment Status
Terminated
Why Stopped
Difficult (slow) Enrollment
Study Start Date
April 2009 (undefined)
Primary Completion Date
February 2011 (Actual)
Study Completion Date
February 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Leadiant Biosciences, Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators hypothesize that the confocal endomicroscopy imaging of the biliary strictures during ERCP will differentiate between benign and malignant strictures in vivo and has increased sensitivity compared to biliary brushing/biopsy, and that direct cholangioscopic guidance of pCLE is more accurate than fluoroscopic guidance.
Detailed Description
Despite recent advances in biliary imaging and biliary tissue acquisition, the diagnosis and tissue-confirmation in suspected malignant biliary obstruction remains challenging. Patients often undergo repeat endoscopic and cross sectional imaging procedures, and even surgical exploration to establish a diagnosis. A major new advancement in cancer imaging is the development of a probe-based confocal endomicroscopy (pCLE) system capable of cellular and sub-cellular imaging of the biliary tree. Preliminary data suggests that pCLE can accurately detect or exclude malignancy within otherwise indeterminate strictures. In this study, we propose to validate these preliminary findings and compare two methods of pCLE image acquisition that are important for clinical translation of the technology. This is a Phase 1 Study: During this study, in vivo microscopic images of 10 benign (post-operative from know benign disease such as orthotopic liver transplant) and 10 malignant (cytology-positive) strictures will be obtained at ERCP. Patients clinical course will be followed and a composite gold standard will be used for comparison to pCLE. These confocal images of biliary lesions will be reviewed side by side, unblinded to the reference standard by the endoscopists. The basic image characteristics allowing distinction between benign and malignant tissue will be established (details of features noted and examined are below). We will also assess whether good quality images can be feasibly obtained without the cholangioscopic guidance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Biliary Stricture
Keywords
Biliary Strictures, Cholangiocarcinoma, ERCP

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
1. To compare confocal image characteristics of benign vs. malignant biliary strictures
Intervention Type
Procedure
Intervention Name(s)
ERCP and Confocal imaging
Intervention Description
A major new advancement in cancer imaging is the development of a probe-based confocal endomicroscopy (pCLE) system capable of cellular and sub-cellular imaging of the biliary tree.
Primary Outcome Measure Information:
Title
Primary Aim: 1. To compare confocal image characteristics of benign vs. malignant biliary strictures.
Time Frame
one year
Secondary Outcome Measure Information:
Title
Secondary Aim: 1. To compare the technical feasibility (percentage of images rated as adequate or better) and the quality of the images obtained via fluoroscopy-guided pCLE versus cholangioscopy-guided pCLE.
Time Frame
One year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pre-ERCP: Age above 18; imaging consistent with stenosis/mass of the hilum/extra-hepatic bile duct with abnormal liver chemistry, or painless jaundice referred for ERCP. Evidence of biliary obstruction as defined by elevated direct bilirubin (> 1.5ULN) and dilation of the common or hepatic ducts > 8mm) on imaging studies. Exclusion Criteria: Unwilling/unable to consent. Definite pancreatic mass on CT/MR. Allergy to Fluorescein. Pregnancy (patient who could be pregnant will undergo pregnancy testing as per routine care) Indwelling metal biliary stent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael B. Wallace, M.D.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32224
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Confocal Endomicroscopy for Biliary Strictures -Phase I

We'll reach out to this number within 24 hrs